[1] |
NHC. Statistical Bulletin on the Development of Health Care in China in 2020. Chin. J. Pract. Rural Doctors. 2021, 28, 1–10.
|
[2] |
Zhao, M.Y.; Zhang, L.Y.; Feng, Z.T.; Fang, Y. Physicians’ knowledge, attitude and practice of generic substitution in China: a cross-sectional online survey. Int. J. Environ. Res. Public Health. 2021, 18, 7749.
|
[3] |
Ess, S.M.; Schneeweiss, S.; Szucs, T.D. European healthcare policies for controlling drug expenditure. PharmacoEconomics. 2003, 21, 89–103.
|
[4] |
Larpparisuth, N.; Pinpaiboon, S.; Ratchawang, N.; Promraj, R.; Skulratanasak, P.; Vongwiwatana, A.; Premasathian, N. A study of the pharmacokinetic comparison between the generic and original form of mycophenolate mofetil among Thai renal transplant patients. Transplant. Proc. 2019, 51, 2629–2632.
|
[5] |
Luo, N.T.; Yue, J.Y.; Zhou, R.J.; Jiang, B. The effects of the National Drug Pooled Procurement (NDPP) pilot program in China. J. Chin. Pharm. Sci. 2022, 31, 212–217.
|
[6] |
Nie, Y.Y.; Wang, H.; Zhou, L.G.; Shi, L.W.; Jiang, B. Pharmacists’ perceptions of generic drugs in China. J. Chin. Pharm. Sci. 2020, 29, 364–368.
|
[7] |
Howard, J.N.; Harris, I.; Frank, G.; Kiptanui, Z.; Qian, J.J.; Hansen, R. Influencers of generic drug utilization: a systematic review. Res. Social Adm. Pharm. 2018, 14, 619–627.
|
[8] |
Nokelainen, H.; Lämsä, E.; Ahonen, R.; Timonen, J. Reasons for allowing and refusing generic substitution and factors determining the choice of an interchangeable prescription medicine: a survey among pharmacy customers in Finland. BMC Health Serv. Res. 2020, 20, 82.
|
[9] |
Drozdowska, A.; Hermanowski, T. Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society. Int. J. Clin. Pharm. 2015, 37, 68–75.
|